AstraZeneca and Merck asserted the approval of LYNPARZA tablets for patients with Ovarian Cancer Read more
OncoSec Medical proclaims preliminary clinical observations of OMS-1140 Clinical Trial of ImmunoPulse in TNBC patients Read more
Eiger Biopharmaceuticals disappointed over negative results of Phase 2 LIBERTY study in PAH Read more
Marina Biotech enters into agreement with Autotelic Bio for developing Marina’s IT-103 Clinical program Read more